Intimation under Regulation 30 is attached herewith.

Corporate Office & Central Laboratory: Survey No 9/1, Near Tulsiyana Industrial Park, Gram Kumerdi, IndoreMp 453555 Tel: +91 731 4243850 - 88 Email: compliance_officer@choksilab.in Website: www.choksilab.in CIN: L85195MP1993PLC007471 To, Date: 03rd November,2026 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Tower Dalal Street, Fort Mumbai-Maharashtra 400001 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: Scrip Code: 526546, ISIN: INE493D01013. Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”) and our intimation dated 21st August, 2026, regarding the inspection from United States Food & Drug Administration (USFDA) at Company’s central laboratory between August 17, 2026 to August 20, 2026 located at Indore. We wish to inform you that on company has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection. You are requested to take the aforesaid on your record and disseminate the same for information to the public. Thanking You Yours faithfully For CHOKSI LABORATORIES LIMITED PRAKHAR DUBEY Company Secretary & Compliance Officer Mem. No.: F14327